Top compounds associated with response to DEDD2


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.085 0.02
mRNA BRD-K49290616 CTRPv2 pan-cancer AAC 0.18 0.02
mRNA CP724714 GDSC1000 pan-cancer AAC 0.079 0.02
mRNA CHEMBL1222381 CTRPv2 pan-cancer AAC 0.079 0.02
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.084 0.02
mRNA lapatinib gCSI pan-cancer AAC 0.13 0.02
mRNA BRD-K75293299 CTRPv2 pan-cancer AAC 0.17 0.02
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.086 0.02
mRNA ibrutinib CTRPv2 pan-cancer AAC 0.098 0.03
mRNA brivanib CTRPv2 pan-cancer AAC -0.082 0.03
Download CSV